Qabbus MB et al., 2022-08: Cervical cancer cell study showing that ivermectin's cytolytic effect in culture coincided with precipitation of solid drug aggregates in the medium, and that filtering out particles larger than 0.2 micrometre abolished the killing, while any anti-proliferative effect persisted only above clinically attainable concentrations.
We observed that ivermectin-induced cell death in two cervical cancer cell lines correlated with the formation of solid ivermectin aggregates in both serum-free and serum-supplemented culture media. Filtration of ivermectin particles >0.2 μm abolished these cytolytic effects in both cell lines.
n/a (PubMed abstract)
Qabbus MB et al., 2022-08: Cervical cancer cell study showing that ivermectin's cytolytic effect in culture coincided with precipitation of solid drug aggregates in the medium, and that filtering out particles larger than 0.2 micrometre abolished the killing, while any anti-proliferative effect persisted only above clinically attainable concentrations. Study type: cervical cancer cell lines (two lines) in vitro, with and without filtration. N: n/a. Country: USA (SUNY Upstate Medical University, Syracuse NY). Dose: concentrations near the aqueous solubility limit of ivermectin; exact range not stated in the abstract. Funder/COI: not stated in the PubMed record. Comparator: filtered vs unfiltered ivermectin solutions. This is the strongest methodological challenge to in vitro anticancer claims: it attributes part of the reported cytotoxicity to a formulation artefact and finds the residual effect only above clinically attainable concentrations. Study type: lab.
